Loading...

Athena Soulika

Title(s)Associate Professor, Dermatology
SchoolUniversity of California, Davis
Phone916-453-5061
Emailasoulika@ucdavis.edu
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nguyen CM, Tartar DM, Bagood MD, So M, Nguyen AV, Gallegos A, Fregoso D, Serrano J, Nguyen D, Degovics D, Adams A, Harouni B, Fuentes JJ, Gareau MG, Crawford RW, Soulika AM, Isseroff RR. Topical Fluoxetine as a Novel Therapeutic That Improves Wound Healing in Diabetic Mice. Diabetes. 2019 Jul; 68(7):1499-1507. PMID: 31048368.
      View in: PubMed
    2. Nguyen AV, Soulika AM. The Dynamics of the Skin's Immune System. Int J Mol Sci. 2019 Apr 12; 20(8). PMID: 31013709.
      View in: PubMed
    3. Adkins Y, Soulika AM, Mackey B, Kelley DS. Docosahexaenoic acid (22:6n-3) Ameliorated the Onset and Severity of Experimental Autoimmune Encephalomyelitis in Mice. Lipids. 2019 01; 54(1):13-23. PMID: 30762234.
      View in: PubMed
    4. Reis ES, Berger N, Wang X, Koutsogiannaki S, Doot RK, Gumas JT, Foukas PG, Resuello RRG, Tuplano JV, Kukis D, Tarantal AF, Young AJ, Kajikawa T, Soulika AM, Mastellos DC, Yancopoulou D, Biglarnia AR, Huber-Lang M, Hajishengallis G, Nilsson B, Lambris JD. Safety profile after prolonged C3 inhibition. Clin Immunol. 2018 12; 197:96-106. PMID: 30217791.
      View in: PubMed
    5. Stoolman JS, Duncker PC, Huber AK, Giles DA, Washnock-Schmid JM, Soulika AM, Segal BM. An IFN?/CXCL2 regulatory pathway determines lesion localization during EAE. J Neuroinflammation. 2018 Jul 16; 15(1):208. PMID: 30012158.
      View in: PubMed
    6. Zhang S, Rasai A, Wang Y, Xu J, Bannerman P, Erol D, Tsegaye D, Wang A, Soulika A, Zhan X, Guo F. The Stem Cell Factor Sox2 Is a Positive Timer of Oligodendrocyte Development in the Postnatal Murine Spinal Cord. Mol Neurobiol. 2018 Dec; 55(12):9001-9015. PMID: 29623612.
      View in: PubMed
    7. Woller SA, Ravula SB, Tucci FC, Beaton G, Corr M, Isseroff RR, Soulika AM, Chigbrow M, Eddinger KA, Yaksh TL. Corrigendum to "Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state" [Brain Behav. Immun. 56 (2016) 271-280]. Brain Behav Immun. 2018 03; 69:632. PMID: 29291934.
      View in: PubMed
    8. Marusina AI, Ono Y, Merleev AA, Shimoda M, Ogawa H, Wang EA, Kondo K, Olney L, Luxardi G, Miyamura Y, Yilma TD, Villalobos IB, Bergstrom JW, Kronenberg DG, Soulika AM, Adamopoulos IE, Maverakis E. CD4+ virtual memory: Antigen-inexperienced T cells reside in the naïve, regulatory, and memory T cell compartments at similar frequencies, implications for autoimmunity. J Autoimmun. 2017 02; 77:76-88. PMID: 27894837.
      View in: PubMed
    9. Lee E, Chamanara S, Pleasure D, Soulika AM. Erratum to: IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J Neuroinflammation. 2016 Aug 30; 13(1):216. PMID: 27576305.
      View in: PubMed
    10. Woller SA, Ravula SB, Tucci FC, Beaton G, Corr M, Isseroff RR, Soulika AM, Chigbrow M, Eddinger KA, Yaksh TL. Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state. Brain Behav Immun. 2016 08; 56:271-80. PMID: 27044335.
      View in: PubMed
    11. Moreno MA, Burns T, Yao P, Miers L, Pleasure D, Soulika AM. Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2016 Jan 15; 290:36-46. PMID: 26711567.
      View in: PubMed
    12. Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, Wiltrout RH, Murphy WJ. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 2015 Aug 18; 43(2):240-50. PMID: 26231116.
      View in: PubMed
    13. Liu C, Shen H, Yi L, Shao P, Soulika AM, Meng X, Xing L, Yan X, Zhang X. Oral administration of aflatoxin G1 induces chronic alveolar inflammation associated with lung tumorigenesis. Toxicol Lett. 2015 Feb 03; 232(3):547-56. PMID: 25445582.
      View in: PubMed
    14. Mills Ko E, Ma JH, Guo F, Miers L, Lee E, Bannerman P, Burns T, Ko D, Sohn J, Soulika AM, Pleasure D. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. J Neuroinflammation. 2014 Jun 12; 11:105. PMID: 24924222.
      View in: PubMed
    15. Moreno M, Bannerman P, Ma J, Guo F, Miers L, Soulika AM, Pleasure D. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J Neurosci. 2014 Jun 11; 34(24):8175-85. PMID: 24920622.
      View in: PubMed
    16. Kim MH, Gorouhi F, Ramirez S, Granick JL, Byrne BA, Soulika AM, Simon SI, Rivkah Isseroff R. Catecholamine stress alters neutrophil trafficking and impairs wound healing by ß2-adrenergic receptor-mediated upregulation of IL-6. J Invest Dermatol. 2014 Mar; 134(3):809-817. PMID: 24121404.
      View in: PubMed
    17. Moreno M, Guo F, Mills Ko E, Bannerman P, Soulika A, Pleasure D. Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE. J Neurol Sci. 2013 Oct 15; 333(1-2):55-9. PMID: 23294494.
      View in: PubMed
    18. Shen H, Yao P, Lee E, Greenhalgh D, Soulika AM. Interferon-gamma inhibits healing post scald burn injury. Wound Repair Regen. 2012 Jul-Aug; 20(4):580-91. PMID: 22712462.
      View in: PubMed
    19. Lee E, Chanamara S, Pleasure D, Soulika AM. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J Neuroinflammation. 2012 Jan 16; 9:7. PMID: 22248039.
      View in: PubMed
    20. Guo F, Maeda Y, Ko EM, Delgado M, Horiuchi M, Soulika A, Miers L, Burns T, Itoh T, Shen H, Lee E, Sohn J, Pleasure D. Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J Neurosci. 2012 Jan 11; 32(2):639-45. PMID: 22238099.
      View in: PubMed
    21. Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D. Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci. 2009 Nov 25; 29(47):14965-79. PMID: 19940192.
      View in: PubMed
    22. Selvaraj V, Soundarapandian MM, Chechneva O, Williams AJ, Sidorov MK, Soulika AM, Pleasure DE, Deng W. PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis. J Biol Chem. 2009 Sep 18; 284(38):26070-84. PMID: 19628872.
      View in: PubMed
    23. Bannerman P, Hahn A, Soulika A, Gallo V, Pleasure D. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia. 2007 Jan 01; 55(1):57-64. PMID: 17009237.
      View in: PubMed
    24. Mack JT, Beljanski V, Soulika AM, Townsend DM, Brown CB, Davis W, Tew KD. "Skittish" Abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system. Mol Cell Biol. 2007 Jan; 27(1):44-53. PMID: 17060448.
      View in: PubMed
    25. Soulika AM, Holland MC, Sfyroera G, Sahu A, Lambris JD. Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3. Mol Immunol. 2006 May; 43(12):2023-9. PMID: 16472861.
      View in: PubMed
    26. Pleasure D, Soulika A, Singh SK, Gallo V, Bannerman P. Inflammation in white matter: clinical and pathophysiological aspects. Ment Retard Dev Disabil Res Rev. 2006; 12(2):141-6. PMID: 16807906.
      View in: PubMed
    27. Beljanski V, Soulika A, Tucker JM, Townsend DM, Davis W, Tew KD. Characterization of the ATPase activity of human ATP-binding cassette transporter-2 (ABCA2). In Vivo. 2005 Jul-Aug; 19(4):657-60. PMID: 15999530.
      View in: PubMed
    28. Tew KD, Boyd JT, Chen ZJ, Davis W, Fazilev F, Findlay V, Gaté L, Ile K, Soulika A, Townsend DM. Glutathione and ABC transporters as determinants of sensitivity to oxidative and nitrosative stress. J Nutr. 2004 Nov; 134(11):3205S-3206S. PMID: 15514308.
      View in: PubMed
    29. Chen ZJ, Vulevic B, Ile KE, Soulika A, Davis W, Reiner PB, Connop BP, Nathwani P, Trojanowski JQ, Tew KD. Association of ABCA2 expression with determinants of Alzheimer's disease. FASEB J. 2004 Jul; 18(10):1129-31. PMID: 15155565.
      View in: PubMed
    30. Ile KE, Davis W, Boyd JT, Soulika AM, Tew KD. Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus. Biochim Biophys Acta. 2004 Apr 16; 1678(1):22-32. PMID: 15093135.
      View in: PubMed
    31. Morikis D, Soulika AM, Mallik B, Klepeis JL, Floudas CA, Lambris JD. Improvement of the anti-C3 activity of compstatin using rational and combinatorial approaches. Biochem Soc Trans. 2004 Feb; 32(Pt 1):28-32. PMID: 14748706.
      View in: PubMed
    32. Soulika AM, Morikis D, Sarrias MR, Roy M, Spruce LA, Sahu A, Lambris JD. Studies of structure-activity relations of complement inhibitor compstatin. J Immunol. 2003 Aug 15; 171(4):1881-90. PMID: 12902490.
      View in: PubMed
    33. Sahu A, Soulika AM, Morikis D, Spruce L, Moore WT, Lambris JD. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol. 2000 Sep 01; 165(5):2491-9. PMID: 10946275.
      View in: PubMed
    34. Soulika AM, Khan MM, Hattori T, Bowen FW, Richardson BA, Hack CE, Sahu A, Edmunds LH, Lambris JD. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol. 2000 Sep; 96(3):212-21. PMID: 10964539.
      View in: PubMed
    35. Lubinski JM, Wang L, Soulika AM, Burger R, Wetsel RA, Colten H, Cohen GH, Eisenberg RJ, Lambris JD, Friedman HM. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol. 1998 Oct; 72(10):8257-63. PMID: 9733869.
      View in: PubMed
    36. Sahu A, Isaacs SN, Soulika AM, Lambris JD. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J Immunol. 1998 Jun 01; 160(11):5596-604. PMID: 9605165.
      View in: PubMed
    37. Sahu A, Sunyer JO, Moore WT, Sarrias MR, Soulika AM, Lambris JD. Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunol Res. 1998; 17(1-2):109-21. PMID: 9479573.
      View in: PubMed
    38. Whitbeck JC, Peng C, Lou H, Xu R, Willis SH, Ponce de Leon M, Peng T, Nicola AV, Montgomery RI, Warner MS, Soulika AM, Spruce LA, Moore WT, Lambris JD, Spear PG, Cohen GH, Eisenberg RJ. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol. 1997 Aug; 71(8):6083-93. PMID: 9223502.
      View in: PubMed
    39. Kozlowski LM, Soulika AM, Silverman GJ, Lambris JD, Levinson AI. Complement activation by a B cell superantigen. J Immunol. 1996 Aug 01; 157(3):1200-6. PMID: 8757626.
      View in: PubMed